BioVentures Investors said today that it closed its 4th medtech fund with $87 million on hand. The Wellesley, Mass.-based venture capital shop said it’s already made 4 investments from its Fund IV, including Eli Lilly (NYSE:LLY) acquisition Locemia Solutions. The other investments were in Deep Vein Medical, which is expected to put its prosthetic venous valve into clinical trials […]